U.S. Gene Therapy Market Size & Outlook, 2023-2030

Name: U.S. Gene Therapy Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The gene therapy market in the United States is expected to reach a projected revenue of US$ 18,484.0 million by 2030. A compound annual growth rate of 18.8% is expected of the United States gene therapy market from 2024 to 2030.

Biotechnology
- Gene Expression & Gene Therapy
  - Gene Therapy Market Outlook

U.S. gene therapy vector type outlook (Revenue, USD million, 2018-2030)
- Lentivirus
- AAV
- RetroVirus & gamma RetroVirus
- Modified Herpes Simplex Virus
- Adenovirus
- Non-viral Plasmid Vector
- Other Vector Type
U.S. gene therapy indication outlook (Revenue, USD million, 2018-2030)
- Acute Lymphoblastic Leukemia (ALL)
- Inherited Retinal Disease
- Large B-cell Lymphoma
- ADA-SCID
- Melanoma (lesions)
- Beta-Thalassemia Major/SCD
- Head & Neck Squamous Cell Carcinoma
- Peripheral arterial disease
- Spinal Muscular Atrophy (SMA)
- Others

U.S. Gene Therapy Market Size & Outlook, 2023-2030

Data Tree

Sign up - it's easy, and free!